MiR-599 serves a suppressive role in anaplastic thyroid cancer by activating the T-cell intracellular antigen

Anaplastic thyroid cancer (ATC) has a mean survival time of 6 months and accounts for 1–2% of all thyroid tumors. Understanding the underlying molecular mechanisms of carcinogenesis and progression in ATC would contribute to the identification of novel therapeutic targets. A previous study revealed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Jian Wei, Zou, Yan Liang, Qian, Jian Tong, Chen, Wen Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755273/
https://www.ncbi.nlm.nih.gov/pubmed/31555352
http://dx.doi.org/10.3892/etm.2019.7864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755273/
https://www.ncbi.nlm.nih.gov/pubmed/31555352
http://dx.doi.org/10.3892/etm.2019.7864

Ejemplares similares